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Symptoms, Signs and Findings in Humans
Exposed to PCBs and Their Derivatives
by G. Reggiani* and R. Bruppacher*t
The records of the health effects caused by some accidental exposure and findings from medical ex-
amination in cases exposed to polybrominated biphenyls (PBB) as well as to polychlorinated biphenyls
(PCB) and their derivatives polychlorinated dibenzofurans (PCDF) and dibenzodioxins (PCDD) have
provided some information for the recognition and classification of their toxicity in humans.
The most impressive clinical features have been presented by the Yusho episode of exposure. Derma-
tologicsignsarethemostpersistent indicatorofaconsiderable uptake. Neurological symptoms, respiratory
findings and impairment of liver function are further aspects of the contamination. Skin manifestations
have been observed also in the newborn infants from mothers exposed to high levels of the substances.
However, the available data make it still hard to assess the clinical picture ofthe effects on humans in
cases of acute exposure and even more the effects on reproduction and long-term effects. Furthermore it
would still be arbitrary to draw a line between the symptoms which can be referred to PCBs and PBBs
alone and those which can be related qualitatively and quantitatively to PCB derivatives (PCDFs, PCDDs,
PCQs).
Introduction
PCBs had and still have a large variety of applica-
tions, mainly in high voltage electronic tools. They are
not counted among the most toxic chemicals but, be-
cause oftheir resistance to degradation in the environ-
ment, their concentration in the food chain and their
persistence inthe human body, they present anincreas-
ing problem as a contaminant and raise questions as to
possible effects on the health of our population.
The human organism may be confronted with PCBs
and their derivatives in various ways: during the na-
mufacturing ofPCBs (mainly in the chemical industry),
during the manufacturing of goods containing PCBs
(mainly in the electric industry but also in the produc-
tion and during use of paints, plastics and carbonless
copy paper), in a contaminated environment and through
consumption of contaminated food. All these situations
can occur in a controlled (chronic) or an uncontrolled
(acute, accidental) way.
Literature is growing, both on the prevalence and on
possible health effects ofman's exposure to PCBs. Oc-
cupational exposure and the contamination of environ-
ment and food have become subjects of intensive
investigations. These epidemiologic studies together
with asteadilyimprovingcapacityto measure lowlevels
of PCBs and their contaminants in the environment as
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well as in tissues ofanimals and man will certainly lead
to a much more precise assessment ofthe risks ofthese
compounds to human health in the future. Today, how-
ever, ourknowledgeoftheclinicaltoxicity ofthese com-
poundsandtheirderivatives stillisderivedmainlyfrom
observations after accidental and high level exposure.
In these cases, however, attention was often focused
only after health effects were noted; consequently the
assessment of exposure was late and incomplete.
We are confronted, also inthe case ofthe PCBs, with
the usual difficulties of clinical toxicology. We usually
have only very limited knowledge of the duration and
theintensityofexposure, onthe route ofadministration
and the latency period to the onset of clinical effects.
Becausethepopulationisinvolvedaccidentally, thekind
and numberofcases are the result ofcircumstances and
many other factors remain uncontrolled that determine
the availability ofthe substance in the body as well as
the susceptibility of the individual and thus the health
effects. Finally, we usually have no baseline data.
In the case ofthe PCB~s we have the additional com-
plication that they represent a group ofchemicals with
different characteristics regardingmetabolism and spe-
cifictoxicity. Furthermore, the situation is complicated
by contamination with other much more toxic com-
pounds, especially the benzofurans.
With respect to the other contributions at this work-
shop, we shall confine ourselves to a presentation ofthe
clinical picture observed after exposure to PCBs. The
kinetics ofthe substance and the epidemiologic aspects,REGGIANI AND BRUPPACHER
Table 1. Ingestion ofPCB and contaminants byYushocases:
Japan 1968.
Average dailydose, mg Averagetotaldose, mg
PCBs 1.9-8.4 500-805
PCDFs 0.01-0.04 3.2-4.4
PCQs 1.7-7.2 450-756
are presented elsewhere (1-3). In the order of their
contribution to clinical toxicological knowledge the ov-
erview will include observations after accidental high
level exposures, chronic occupational exposure and only
touch on exposure through food and environment. The
picture presented must be selective and cannot be com-
plete, but we hope that it will contain the outlines most
important to the clinicians.
Table2. Yusho cases,Japan, 1968-1970: clinical symptomatology.
% showingor
Symptoms and signs reporting
Dermatologicalmanifestationsa 82-89
Acneform eruptions
Distinctive hairfollicles
Redplaques onlimbs
Darkbrownpigmentation ofnails, skin,
mucuousmembranes
Itchingandsweatingofpalms
Ocularmanifestations 83-88
Eye discharge
Swellingofuppereyelid
Hyperemiaofconjunctiva
Cystformationoftarsalglands
Pigmentationofeyelid
Pigmentation ofconjunctiva
Transientvisualdisturbanceb
Episodes of Accidental High Level
Exposures
Yusho/Yu-Cheng
Much of our knowledge of the effects of PCBs and
their contaminants in the human body still is derived
from the so-called "Yusho" episodes. Approximately 1600
residents were exposed to a mixture ofpolychlorinated
biphenyls, polychlorinated dibenzufurans (PCDFs) and
polychlorinated quaterphenyls (PCQs) in 1968 in west-
ern parts ofJapan. They had consumed rice oil contam-
inated with Kanechlor400, aheattransfermedium, and
developed severe clinical symptoms (4-7). A similar
event occurred in 1978 in Central Taiwan, where 2000
residents were exposed to a similar mixture of PCBs,
PCDFsandPCQs(8,9). Theclinical symptomsobserved
(called Yusho for theJapanese occurrence and Yu-Cheng
in the Taiwanese cases) have become a kind of a ref-
erence profile forintoxicationsinvolvingPCB mixtures,
because the data available from these two episodes still
arethemostpreciseinformation wehaveaboutthedaily
intake, length of exposure and total dosage, as well as
on the latency to onset of effects and time of the ap-
pearance ofthe single symptoms and signs ofthe clinical
picture of such a poisoning.
Dosesingested duringseveralmonthsintheJapanese
Yusho cases are given in Table 1, and the resulting
clinical symptoms, signs and findings are summarized
inTable2. Skinandocularmanifestations werethemost
dominant. They diminished gradually over the next ten
years (10). The same pattern of ocular manifestations
has also been reported in the Taiwanese cases (11).
Symptoms of the nervous system and disturbances of
the liver function were less frequent and less severe.
Chronic bronchitis correlated with PCB concentrations
in sputum and blood and persisted in 20% of the cases
for more than ten years. A threefold increase in tri-
glycerides serum levels returned to normal after 5-7
years.
Irregular menstrual cycles were noted in 60% of the
exposed women of child bearing age.
Hearingdifficulties
Headaches, vomiting, diarrhea
Numbnessoflimbs, weakness, muscle spasm
Sensoryandmotorconduction
Respiratory/immunologic
Chronicbronchitis"
PCB in sputum
Lowerserum Igaand IgM levels
Hepatic andmetabolic
Jaundiced
Elevated serumtriglycerides (3-fold)e
18
17-39
32-39
9
40
10
Reproductive
Irregularmenstrual cycles 60
Fetal/newborn (babies exposed inutero, N = 13)
Stillbirths (N = 2)
"Colacolored" (N = 1)
Lowbirthweight
Elevatedbilirubin
Conjunctivities
Enlarged Meibomianglands
Chloracne
Darkbrownpigmentation ofskin(groin, gums
andnails)
Hypoplastic nails
Scalpcalcification, natalteeth (N =2)
Retardedgrowth(severalyears)
"Soft"neurologicsigns (atage7-9)
a Diminishinggradually over the next 10 years; some subcutaneous
cystformationpersisting.
b In some cases still presentafter 10years.
SeveritycorrelatedwithPCB bloodlevel.
Noliverfunctionabnornality in most cases.
Normalafter5-7years.
Low birth weight, elevated bilirubin, conjunctivitis,
enlargement of Meibomian glands, hypoplastic nails,
dark-brownpigmentation ofskin, gums, nailsandgroin,
which gradually faded, retarded growth for a few years
(12) and abnormal number and shape ofteeth were ob-
served in the newborns fromexposed pregnant women.
Some developed chloracne. "Soft" neurological signs
were observed at ages 7 to 9 (13).
Similar symptoms were observed amongthe exposed
Taiwanese population.
The latency period of clinical symptoms was around
two months in theJapan episode; in the Taiwan episode
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it was 2.7 months. A detailed account ofthe symptom-
atology ofthe two Yusho episodes has been given in an
earlier paper (14).
The Michigan PBB Incident
Three commercial products, hexa-, octa-and decabro-
mobiphenyl, known under the tradenames of Firemas-
ter, Bromkal and Flammex, have been used mainly as
flame retardants until 1974, when their production was
stopped in the U.S. (15). They are of interest in the
toxicology ofhalogenated biphenyls, because theywere
the main factors in another episode of considerable
proportions.
In 1973, a mixture of the three polybrominated bi-
phenyls was mixed accidentally into animal feed (Nu-
trimaster) in a factory of the Michigan Chemical
Corporation, whereby 1000-2000 lb of a fire retardant
was added to the livestock food supply of Northern
Michigan. The accident was revealed by adverse health
effects observed in the cattle in several dairy herds:
milk production decreased, the cattle lost weight and
developed abnormal hooves with lameness; abortions
occurred also in swine. Animals sent to slaughter pre-
sented enlargment of the liver. PBB levels in the feed
ranged from2.4to4300ppm, incontaminated milkfrom
2.8 to 270 ppm.
Until the affected herds and flocks were quarantined
in spring 1974, over 10,000 Michigan residents were
exposed to PBB through the consumption ofmilk, meat
and other dairy products. Blood levels measured in two
Table 3. Michigan PBB incident: symptoms and conditions
by PBB serum level.a
Serum PBB concentrations, ppb
Symptom reported 0 1 2-3 4-9 10-19 20-99 100+
(incidence in %)
by ca. 3300 subjects
Skin rash (7.8) 9.0 8.5 8.4 7.2 8.3 6.3 4.1
Fatigue (38.3) 46.5 40.1 40.7 38.1 37.8 28.7 27.4
Joint pains (28.6) 42.9 32.7 29.8 26.4 28.4 21.6 17.1
Hepatitis (1.4) 4.5 1.4 1.8 1.4 1.3 -
Diabetes (2.4) 4.7 2.9 2.4 1.8 1.9 3.3 -
Benign tumors (0.6) - 0.9 0.5 0.5 1.0 0.4 1.8
Cancer (all) (5.3) 2.7 7.5 5.6 4.3 5.3 3.8 2.6
a Data of Budd et al. (16).
samples of this population were significantly higher in
thepeoplefromquarantinedfarms ascomparedtothose
from the nonquarantined farms, although low levels were
observed also in the first group.
Health complaints, such as numbness, stomach pains,
headache, fatigue, anxiety and abnormal liver function
tests in people exposed were reported. The Michigan
Department of Health undertook a series of studies in
summer and autumn 1974. In a group of 300 exposed
people who had worked or lived in the quarantined fanns
for six months or more since the accident, no unusual
abnormalties of the heart, liver, nervous system, uri-
nalysis, blood counts and all other medical conditions
examined could be found, which did not occur also in a
matching control group. Several ofthe exposed women
delivered normalbabies. PBB levels inblood andbreast
milk were higher, but there was no relationship with
complaints or abnormal medical condition.
Three years later another study on more than 3300
persons included groups with different levels of expo-
sure. PBB serum levels were highest in plant workers
manufacturing PBB (w = 108.7 ppb) and lowest in a
volunteer group (x = 3.2 ppb). Other groups corre-
sponded to the estimated level of exposure. There was
no positive association between serum concentration of
PBB and reported symptom or disease frequencies
(16,17).
Several retrospective studies were concerned with
specific symptomatology. Skin manifestations reported
by Chanda (18) are summarized in Table 4. Bromacne
was observed in 13% of53 Michigan chemical workers.
It was the only sign of exposure in these cases with the
highest PBB blood levels.
The route of exposure (contact and inhalation) might
be an explanation for the surprising absence of other
skin lesions noted in the Michigan farmer population
and even inthe controls taken fromfarms in Wisconsin.
With the exception of bromacne, there is hardly any
difference in prevalence ofobjective signs between the
quarantined and nonquarantined farms foritching, dry-
ness and folliculitis, not even with the control group,
andthere was nopositivecorrelationbetweentheseskin
lestions and serum PBB levels.
Neurological symptoms were the object of a similar
study of664 Michigan farmers including 153 Wisconsin
Table 4. Michigan PBB incident: skin symptomatology.a
Quarantined farms Nonquarantined farms Plant workers Controls
(N= 485) (N= 299) (N = 53) (N = 228)
Serum PBB (ppb) 21 4.2 123
Symptoms
Peeling and scaling 17 18 9
Erythema 11 13 5
Hair loss 13 11 5
Nail growth 7 11
Sweating 21 24 13
Itching and dryness 31 32 29
Folliculitis 23 24 30
Bromacne 2 5 13
a Data of Chanda et al. (18).
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dairy farmers as controls (19). Subjective neurologic
symptomswerefound morefrequentlyamongthe Mich-
igan population, but the serum PBB levels did not cor-
relate with subjective and objective neurological
symptoms. A negative correlation was found, however,
between performance test scores and the blood chem-
istry abnormalities (increased SGPT and SGOT) ob-
served in the exposed group.
Astudy ofthe immunocapability in41 cases withhigh
serum PBB levels (7300 ppb), in 56 cases with levels of
1 to 9, and 7 cases with levels less than 1 ppb showed
no difference in the lymphocyte count or functions (17).
However, 15% of the exposed persons were found to
have two or more abnormalities of in vitro lymphocyte
functions.
A second study of the immune capacity was per-
formedin45adult dairyfarmresidents ofMichiganwho
consumed PBB-contaminated food for a period of 3
months to 4 years in comparison to control groups of
farmers in Wisconsin and residents of the New York
area. The Michigangroup showed asignificant decrease
of T- and B-lymphocyte subpopulations in 35% of the
cases andimpaired lymphocyte function, i.e., decreased
response to mitogens (20). The analysis of the clinical
history ofthe symptoms and biochemical abnormalities
in the exposed farmers did not reveal any increase of
acute or chronic minor or major infections (21).
Human studies have largely failed to demonstrate a
clear-cutpatternofillnesscommontoPBB-exposedper-
sons. There are, also, different views about the more
subtleneuropsychologic effectsintheoffspring(22), and
results of the investigations of developmental abilities
remain controversial, too (23,24).
Other Incidents
Another accident involving animal feed occurred
through a transformer leak in a hog processing plant in
Montana, which lead to a widespread contamination with
PCBs; this episode, however, remained without clinical
consequences (25).
The clinical observations after chemical fires are dif-
ficult to separate from the general effects caused by
smoke and fumes (26). Transformer and capacitor fires
are extensively covered elsewhere (27-29).
Chronic Occupational Exposure
Reports on effects ofoccupational exposure date far-
ther back (30), but the Yusho episode has directed at-
tentionagaintothepossiblehealtheffectofoccupational
exposures to PCBs.
In Japan, a 20-30% incidence of dermal symptoms,
consisting of "distinctive hair follicles and pimple-like
skin eruptions" in exposed areas such as the face, neck
and forearm was reported among employees in a ca-
pacitor factory (31). They had used pentachlorobiphen-
yls and Kanechlor300. After 1972, whenthe use ofPCB
was suspended, skin findings abated. Persons working
in environments that contained 0.02-0.3 ppm of PCBs
showed "brown chromodermatosis" and "acneform ex-
anthema" ofhands andfingers and nailbed and comedos
or acneform exanthema of the jaw, back and thighs.
These signs disappeared one month after stopping han-
dling of PCBs. In another factory with environmental
concentrations of 0.002 ppm no dermal manifestations
were observed (32).
Ouw and colleagues (33) reported complaints of a
burning sensation of the face and hands, nausea and a
persistent body odor in a study of 34 workers exposed
to Aroclor 1242 in a capacitator manufacturing plant in
Australia. One had chloracne and five suffered from an
eczematous rash on the legs and hands. Although he-
patic function tests were normal, the mean blood Aro-
clorlevel in the exposed group (400 ppb) was significantly
higher than in a control group of 30 unexposed
volunteers.
A study of 5 workers using Aroclor 1016 from a ca-
pacitator manufacturing plant in New York State by
Alvares and co-workers (34) did not reveal acneform
skin lesions or other clinical manifestations suggestive
ofPCBstoxicity. Liverandkidneyfunctiontests, serum
electrophoresis, triglycerides and cholesterol levels were
within normal limits. Nerve conduction velocity studies
gave normal results. Nevertheless he noted signifi-
cantly lower halflives ofantipyrine (10.5 hr vs. 15.6 hr
in nonexposed controls) and an increased metabolic
clearance rate suggestingabarbiturate type ofinducing
drug metabolism in man which could also be demon-
strated in animal experiments.
A detailed picture of clinical manifestations in work-
ers exposed to dielectric fluids containing PCBs was
elaborated during a clinical field survey of326 capacitor
manufacturingworkersbyFischbeinandcolleagues and
reported in great detail (35,36). Of the subjects exam-
ined, 90% were employed for more than 5 years, 40%
for 20 years or longer. Reported symptomatology was
dominated by dermatological symptoms: mainly a skin
rash (39%), a burning sensation (25%) and acne (11%).
However, the prevalence ofreported pigmentation dis-
turbances, thickening of the skin and discoloration of
the nails, generally considered to be typical of PCB
poisoning, was markedly lower (3%). On physical ex-
aminations almost 40% presented abnormalities includ-
ing erythema, swelling, dryness and thickening. 6% were
found tohave acneform eruptions, and 15% showed con-
junctivalandpalpebralabnormaltiesincludingpalpebral
hyperpigmentation and edema. Abnormal secretion from
the eyes and the typical enlargement ofthe Meibomian
glands were seen in 2% respectively 1%.
Neurologic symptoms were cited by 39% ofthe males
and58%ofthefemaleworkers. Theyincludedheadache,
dizziness, depression, sleeplessness, nervousness, fa-
tigue, somnolence and memory loss. But routine neu-
rologic examination did not reveal any remarkable
prevalence of abnormalities.
Gastrointestinal symptomslikeanorexia, weightloss,
nausea, vomiting and abdominal pain were reported by
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13% of the male and 23% of the female workers and
muscle and joint pain also was indicated twice as often
by women (15%) than by men (8%).
Upper respiratory irritation was indicated by 48%,
and ahistory oftightness in the chest was given by 10%
ofthe group. In 14% the forced vital capacity was less
than 80% ofthe value predicted and in 11% arestrictive
impairment was diagnosed. X-rays of the lung were
normal except in one case.
Laboratory examination yielded generally normal re-
sults of biochemical and hematological tests. Both for
lower and higher homologs ofPCBs, a good correlation
ofmean plasma levels with the history ofexposure was
noted. However, no association was found between re-
ported symptoms and duration of employment. There
was also no correlation between reported symptoma-
tology and plasma levels of lower or higher homologs
of PCBs. On examination only dermatologic findings
showed a correlation and this with the higher homologs
of PCBs in blood. Ofthe laboratory tests SGOT levels
did correlate with both lower and higher homologs of
PCBs.
In another survey conducted by the U.S. Center for
Disease Control and the National Institute for Occu-
pational Safety and Health in three groups ofworkers
occupationally exposed topolychlorinated biphenyls, no
clinical abnormalities attributable to exposure to PCB
could be observed, while symptoms suggestive of mu-
cous membrane and skin irritation of systemic malaise
and altered peripheral sensation were indicated more
freqently by persons with higher concentrations ofserum
PCBs. Positive correlations were also found with lower
enzyme activities, glutamic-oxalacetic transaminase
(SGOT), serum gamma-glutamyl transpeptidase
(GGTP), and plasma triglycerides. The high density li-
poprotein-cholesterol showed an inverse correlation with
plasma PCB (37).
In Italy, Maroni and colleagues (38) investigated 80
workers (40 males and 40 females) exposed to Pyralene
3010 or to Apirolio in capacitor manufacturing and test-
ing plants (both PCB mixtures contain 42% chlorine).
Absorption had occurred mainly through the skin. Fif-
teen workers were found to have skin diseases; ofthese
four had chloracne, four folliculitis, one oil dermatitis,
one juvenile acne and five dermatitis due to irritative
or allergic agents; 16 workers showed hepatic involve-
ment, consisting most often of hepatomegaly with an
increase inserumlowerenzymelevels (GGT, AST, ALT
and OCT). All of these were men. In two workers,
bleeding cavernous hemangiomas were discovered, in
one case associated with chronic myelocytic leukemia.
No definite association was found between chloracne
and blood PCB concentrations but particularly trichlo-
robiphenyl blood concentrations correlated significantly
with abnormal liver findings which were considered as
clinical signs of hepatic microsomal enzyme induction.
The demonstrated long-term toxic effects, including
liver tumors and other liver diseases, in exposed labo-
ratory animals (39-42) has prompted a retrospective
cohort mortality study of2567 workers with a total ex-
perience of39,018 person years in two plants who were
employed for at least 3 months in areas where PCBs
were used. Mortality from all causes and from cancer
was lower than expected (163 vs. 182.4 and 39 vs. 43.8
respectively). Excess mortality was noted for cancer of
the rectum, of the liver and to a less degree, of the
breast. None of these excesses were statistically sig-
nificant. Earlier reports of an increase of cancer ofthe
pancreas, of lung cancer and ofmelanoma could not be
confirmed. Experiences on long-term effects, however,
is still very limited.
Exposure of the General Population
Through routine waste disposal or accidental leakage
polychlorinated biphenyls are nowwidely distributed in
the environment. Like TCDD residues they are accu-
mulated and concentrated by fish and non occupational
human exposure to PCBs occurs now primarily through
the diet.
Relations with PCB levels or with clinical symptoms
are, however, difficult to establish even in situations
where the contamination is unusually high. Use ofsew-
age sludge containing close to 500 ppm of PCBs for
gardening purposes was not significantly associated with
PBC-blood levels and no clinical signs of PCB toxicity
could be noted (43). There was no relation to haema-
tologic, hepatic or renal function tests. However, plas-
matriglyceride levelsincreased significantlywith serum
PCB concentration indicating that PCB may alter lipid
metabolism at levels of exposure and bioaccumulation
insufficient to produce overt symptoms. In a survey of
acommunityinAlabama, knownforunusuallyhighDTT
exposure, average blood levels of 17.2 ppb were found
(44). They were positively related to age, even when
controlled forothervariables associatedwithPCBlevel:
sex, local fish consumption, obesity, serum cholesterol
levels, and alcohol consumption. No major point source
of PCB contamination could be found and fish taken in
thedrainage ofamajorpopulationcenterhadmeanPCB
levels below the then in force FDA tolerance of 5 mg/
kg. PCB levels were positively associated with -y-glu-
tamyltranspeptidase, serum cholesterol and blood pres-
sure. The blood presure association was independent of
age, sex, body mass index and social class. An associ-
ation with triglycerides could not be found, and an in-
verse association with high-density lipoprotein-
cholesterol could notbeconfirmed either. However, this
again raises the question about the long-term implica-
tion with respect to cardiovascular disease.
There are numerous other studies on PCB levels and
health findings in the general population. Relationships
however, are usually erratic and difficult to interpret.
On the other hand, PCB levels were examined in pop-
ulations with specific complaints. Berovici and Wasser-
man (45) found, e.g., higher PCB serum levels in
comparison with a control group in 7 out of 15 cases of
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missed abortions and in 8 out of 17 women with pre-
mature delivery.
The newborn and infant may be more exposed be-
cause the only way to excrete large amounts of PCBs
is through lactation. In a recent study in Michigan re-
ported by Wickizer and co-workers (46), 1057 breast
milk samples tested contained at least trace amounts
but up to 5.1 ppm on fat weight basis ofPCB residues.
Although there is no clear indication that this level of
contamination poses significant health hazards to the
infant, it does give reason forconcern. Wickizerrepeats
the earlier advice of the American Academy of Pedi-
atrics (47) that the breast milk ofnursing mothers with
potentially high exposures to PCB should be tested and
breast feeding should be limted in mothers whose milk
fat is found to be highly contaminated.
Contaminants
Polychlorinated dibenzofurans (PCDFs) are formed
in the commercial synthesis of PCBs, they are struc-
turally and toxicologically similar to the chlorinated
dioxins and concentrate likewise in the liver as well as
to a lesser degree in the adipose tissue. The 2,3,7,8-
tetrachlorodibenzofuran is the most toxic ofthe PCDFs
and orders ofmagnitude more toxic than PCBs. It has
asimilarstructure asthecorresponding polychlorinated
dibenzodioxin 2,3,7,8-TCDD (48). Rather high quan-
tities ofPCDFs have been found in Yusho oil and in the
tissues of people who had suffered Yusho disease.
Polychlorinated dibenzodioxins (PCDDs) are usually
discussed in connection with herbicides, fungicides and
as a contaminant of the production of chlorophenols.
Others are formed duringthe combustion ofchlorinated
hydrocarbons, also of chlorobenzenes used together with
PCBs in transformers and capacitors. The clinical ob-
servations after exposure to PCDDs, particularly 2,3,7,8-
TCDD, are the subject of an extensive literature sum-
marized elsewhere (49).
Summary and Conclusions
Itisnoteasyandnotreallypossibletoputthefindings
described in the literature into a simple and compre-
hensive picture. Such a picture must be somewhat ar-
bitrary, in view ofthe often conflicting reports and the
difficulties ofobservationalexperience described above.
By far the most impressive clinical picture is pre-
sentedbythe Yusho cases. This, however, is verylikely
due to the contaminants and notonlytothe PCBsthem-
selves. The route ofexposure and absorption as well as
the level of exposure have been often advocated as a
possible explanation for the discrepancy between the
clinical picture reported in cases of occupational expo-
sure (mainly through skin and inhalation) and in cases
ofaccidental exposure (mainly through the gastrointes-
tinal tract). Yet in the final analysis it is the chemical
which is circulating in the blood stream, stored in the
fat tissues, muscle, bones and organs which is deter-
minant for the toxicity.
Blood levels are highest in the occupationally ex-
posed;however, theyareoftendifficulttocorrelatewith
the clinical findings. Such a lack of correlation is well
known in clinical pharmacology for many lipophilic sub-
stances (e.g., Vitamin A). Blood and tissue levels are
necessary to determine that the person has actually
taken up the substance and not only had the chance to
do so. The contrastto thebackground level and thereby
the quantitative aspect may be of use in determining
the uptake in a specific situation.
Dermatologic signs are the most impressive indicator
of a considerable uptake. Pigmentation and ocular
symptoms are frequently seen inpoisonings where PCB
is involved but probably are due to the contaminants.
The same is true for chloracne, where the benzofurans
probably are mainly responsible in the Yusho cases. At
least, chloracne is relatively specific for a small group
of chemicals. Cases of chloracne and bromacne among
workers exposed to PCBs and PBBs for longer periods
have been observed, but there seems to be no corre-
lation between duration and level of exposure, blood
concentration and clinical picture. Skin manifestations
healslowly(48) inabout80% ofthecases. Insomecases,
sequelae remain which can be detected clinically when
other symptoms and signs have disappeared.
Althoughthere maybe anotableincreaseinthe prev-
alence of subjective neurologic symptoms (headache,
dizziness, fatigue, nauseaand vomiting) orofperipheral
nerve symptoms (like numbness, joint and muscle pains),
they are so frequent in control subjects that they are
of little significance to the clinician.
More impressive are the respiratory findings in high
level exposure, however there are usually many con-
founding influences. Impairment of other physiologic
functions, such as the liver, fat and porphyrin metab-
olism are less frequent and less severe. In high-level
exposure, peripheral neuropathies, liver function im-
pairment, and increase ofserum triglycerides return to
normal afterafewmonths to afewyears afterexposure
has ceased, depending on the severity ofthe poisoning.
The correlation with blood fat levels and blood pressure
in the general population with PCB levels is interesting
but needs further confirmation.
Increased enzyme activity and drug metabolism was
observed in cases where clinical history and physical
examination revealed no acneform skin lesions or other
manifestations suggestive ofPCB toxicity. The clinical
consequences ofthe changes found in the cell mediated
immunologic response are not yet clear.
One ofthe most worrisome problems concerns repro-
duction and child development. The effect on reprod-
uctivity is hard to assess because of the small number
ofcases reported with known exposure or known blood
levels. Conception seems to be possible even in cases
of overt poisoning, and pregnancy seems to follow a
normal course. Early and late fetal losses may perhaps
be related. The newborn child is extensively exposed
to the chemicals through the mother, which leads to
specific skin manifestations, to decreased birth weight,
and retarded development with very high levels. Con-
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genital anomalies have not been reported with the ex-
ception of disorders of tooth eruption and retarded
growth for several years as a late manifestation in the
case of overt poisoning. The immune response of the
newborns has not been examined, though the rather
high frequency of acute infections during the first year
oflife in Yusho children may point to an impairment of
immune capability.
Theconcentration oftheomniprevalent PCBinbreast
milk may lead to a high body burden ofthe infant. Al-
thoughthere stillis noclearindication thattheresulting
levels pose significant health hazards, precautionary
measures seem indicated.
On the whole, our view ofthe effects ofthe intake of
PCBs and theircontaminants stillisratherblurred. But
how could we get a clear picture on the clinical side?
The determination oftheintake, the actualbody burden
should be improved, taking advantage ofthe increased
sensitivity ofanalytical methods for assessing evidence
ofabsorption in man. Cinical symptomatology can then
be estimated in relation to the kinetics ofthe chemicals
inthebody. Signsofphysiologicaladjustments oforgans
and functions involved in the detoxification process
should thereby not be considered adverse or irrever-
sible health effects. Finally, long-term effects can only
be evaluated by well planned and well conducted epi-
demiological studies.
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